Liver fibrosis
2005/02/01 by Ramón Bataller, David A. Brenner · 38 citations
Medicine · #Liver Disease Diagnosis and Treatment #Liver physiology and pathology #Hepatitis B Virus Studies
paper · pdf · doi:10.1172/jci24282
Abstract
Liver fibrosis is the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases. Advanced liver fibrosis results in cirrhosis, liver failure, and portal hypertension and often requires liver transplantation. Our knowledge of the cellular and molecular mechanisms of liver fibrosis has greatly advanced. Activated hepatic stellate cells, portal fibroblasts, and myofibroblasts of bone marrow origin have been identified as major collagen-producing cells in the injured liver. These cells are activated by fibrogenic cytokines such as TGF-beta1, angiotensin II, and leptin. Reversibility of advanced liver fibrosis in patients has been recently documented, which has stimulated researchers to develop antifibrotic drugs. Emerging antifibrotic therapies are aimed at inhibiting the accumulation of fibrogenic cells and/or preventing the deposition of extracellular matrix proteins. Although many therapeutic interventions are effective in experimental models of liver fibrosis, their efficacy and safety in humans is unknown. This review summarizes recent progress in the study of the pathogenesis and diagnosis of liver fibrosis and discusses current antifibrotic strategies.
Cited by
- Occult Hepatitis B Virus Infection and Liver Fibrosis in Chinese Patients
- Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut
- TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis
- Combined quercetin and simvastatin attenuate hepatic fibrosis in rats by modulating SphK1/NLRP3 pathways
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
- Integrative Omics Reveal Female‐Specific Benefits of p16 <sup>+</sup> Cell Clearance in Aging Mice
- Fibroblasts: a diverse population of cells balancing homeostasis, wound healing, regeneration, inflammation, fibrosis, and cancer across organs
- RNA-binding protein LARP6 coordinates hepatic stellate cell activation and liver fibrosis
- Transforming Growth Factor Beta Signaling in Hepatocytes Participates in Steatohepatitis Through Regulation of Cell Death and Lipid Metabolism in Mice
- Macrophages expressing macrophage receptor with collagen structure attenuate liver fibrosis through a tissue restoration phenotype
- Novel RORγt inverse agonists limit IL-17-mediated liver inflammation and fibrosis
- High-throughput multiparametric live-cell and immunofluorescence analyses demonstrate antifibrotic bioactivities of O. basilicum and A. membranaceus hairy roots on human hepatic stellate cells
- PRMT1 in Health and Disease: Emerging Perspectives From Molecular Mechanisms to Therapeutic Strategies
- Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. [europepmc]
- Liver cirrhosis. [europepmc]
- Senescence of activated stellate cells limits liver fibrosis. [europepmc]
- Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. [europepmc]
- Macrophages: master regulators of inflammation and fibrosis. [europepmc]
- Enteric dysbiosis associated with a mouse model of alcoholic liver disease. [europepmc]
- NF-κB in the liver--linking injury, fibrosis and hepatocellular carcinoma. [europepmc]
- PAI-1 in tissue fibrosis. [europepmc]
- Mechanisms of hepatic fibrogenesis. [europepmc]
- Alcoholic liver disease: pathogenesis and new therapeutic targets. [europepmc]
- Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. [europepmc]
- Mechanisms of fibrosis: therapeutic translation for fibrotic disease. [europepmc]
- Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. [europepmc]
- Non-cell-autonomous tumor suppression by p53. [europepmc]
- A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. [europepmc]
- Divergent angiocrine signals from vascular niche balance liver regeneration and fibrosis. [europepmc]
- Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology. [europepmc]
- Hypoxia and the extracellular matrix: drivers of tumour metastasis. [europepmc]
- EMT and tumor metastasis. [europepmc]
- Liver inflammation and fibrosis. [europepmc]
- Extracellular matrix as a driver of progressive fibrosis. [europepmc]
- TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. [europepmc]
- Fibrosis and cancer: A strained relationship. [europepmc]
- Wound healing, fibroblast heterogeneity, and fibrosis. [europepmc]
- The Hippo signalling pathway and its implications in human health and diseases. [europepmc]
Related